Business
AstraZeneca Expands Boston Operations
AstraZeneca opened a new R&D site in Kendall Square, Boston, investing $1 billion. The move comes after the company's recent dealmaking with Chinese firms.
Coverage timeline — 1 article
STAT News
AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled center of U.S. biotechnology after a spate of Chinese dealmaking.
2026-10-06 14:41 UTC